McKinsey: Using Logistics To Meet Testing Demands

By Jack Grimshaw
Diagnostic supply shortages continue to impede countries as they look to improve COVID-19 testing - how can this be overcome...

Testing is considered a crucial aspect for tackling and containing the COVID-19 pandemic, but constraints surrounding the supply of diagnostic equipment is significantly hindering a vast majority of countries still struggling with the virus. 

As one of the largest natural crises ever to hit the world, the outbreak of the coronavirus has presented numerous challenges that the majority of countries have found difficult to mitigate. Molecular assays, a technology that focuses and identifies the viral genetic materials and detects the presence of the virus within an individual, and immunoassays, which work to focus on identifying and detecting antigens or antibodies, are the two main types of COVID-19 testing.

Both types are essential to the success of tackling the virus, but the focus of the McKinsey article we’re breaking down is on the molecular-assay testing.

As the method which is widely regarded as the test which is most able to detect active infections, molecular-assay testing requires a number of lab-based resources to meet demands. The United States currently has the capacity to carry out approximately three and a half million molecular assay tests every week, which is significantly below the number required to tackle the pandemic - which currently sits at roughly six million tests per week with a partially reopened country.

The supply of tests needs to be increased dramatically before scientists and doctors can have any hope of meeting the needs of the world. The main obstacles standing in the way of delivering laboratory testing equipments are sample collection, test execution, testing-capacity management, logistics and data management.

Logistics companies, as they have done throughout a number of natural crises and issues throughout history, stand to play a crucial, essential role to successful testing. The supply chain has never been so important, with shipments of components from sources to different locations around the world, from laboratories to hospitals, effective management of logistics must be done right.

The transportation of samples, from the beginning of their journeys at the collection point, right through to the end result in laboratories, is also important to get right. Without the efficient, successful deliveries of these essential goods, labs will be incapable of meeting the worldwide testing targets, which could eventually, potentially, amount to 20 million every day.

Whilst not the largest obstacle standing in the way of identifying cases, logistics is still problematic and could become more of a challenge for countries attempting to improve detection, as demand will continue to rise exponentially and pressure will be constantly added.


Featured Articles

Supply Chain Digital Show: Procurement burnout in spotlight

Supply Chain Digital Show features Katie McEwan, a Community Advocate for supplier data firm TealBook. She discusses how to remedy burnout in procurement

China policy sees Apple CEO Tim Cook go from hero to zero

With his eggs-in-in-one-basket China policy, Apple CEO Tim Cook is under intense pressure to loosen ties with China and diversify its manufacturing base

How will supply chain get tanks to front line in Ukraine?

The US, UK and EU are providing Ukraine with tanks, but what are the procurement & logistics challenges of getting tanks from manufacturers to front line?

Logistics round-up: Amazon axes jobs; DHL lauded as employer


Data-driven omnichannel 'is future for retail supply chains'

Digital Supply Chain

Gartner in plastic packaging U-turn greenwashing warning